Discovery of TIBO, a New Family of HIV-1-Specific Reverse Transcriptase Inhibitors

This publication has 27 references indexed in Scilit:

• Differential inhibitory effects of TIBO derivatives on different strains of simian immunodeficiency virus
  Journal of General Virology, 1992
• Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives. 2
  Journal of Medicinal Chemistry, 1991
• Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives
  Journal of Medicinal Chemistry, 1991
• Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative
  Biochemical and Biophysical Research Communications, 1989
• The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987
• Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro
  Biochemical and Biophysical Research Communications, 1987
• ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX
  The Lancet, 1986
• Selective cytotoxicity of aids virus infection towards HTLV-I-transformed cell lines
  International Journal of Cancer, 1985
• Suramin Protection of T Cells in Vitro Against Infectivity and Cytopathic Effect of HTLV-III
  Science, 1984
• Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses
  Cancer Letters, 1979